Marzena Dominiak | Medicine | Excellence in Research

Prof Dr. Marzena Dominiak l Medicine | Excellence in Research

Wroclaw Medical University- Vice Rector For Strategic Initiatives, Poland

Author Profiles

Scopus

Orcid

Prof. Dr. Marzena Dominiak 🦷

Vice Rector for Strategic Initiatives, Wroclaw Medical University, Poland

Educational Background 📚

Prof. Dr. Marzena Dominiak holds a Doctorate in Dentistry (Dr. med. dent.) from Silesian Piast Medical University of Wroclaw, Poland, which she completed in 1994. She specialized in dental surgery, obtaining her first and second degrees in dental surgery in 1997 and 2000, respectively. In 2002, she earned her PhD at the same university. Later, in 2010, she achieved her Habilitation at Pomeranian Szczecin Medical University, and in 2015, she was granted the title of Full Professor by the President of the Republic of Poland.

Professional Experience 👩‍⚕️

Prof. Dr. Dominiak has had an illustrious career in both academia and clinical practice. From 1994 to 1997, she worked as an assistant in the Dental Surgery Ward at the 4th Military Clinical Hospital in Wroclaw. She then held various positions at Silesian Piast Medical University, progressing from Clinical Assistant to Adjunct and Associate Professor. Her international experience includes serving as a Visiting Professor at TU Dresden, Germany, between 2011 and 2015. She has also held leadership roles in professional dental organizations, including as President of the Lower Silesian Branch of the Polish Dental Association and Vice Rector for Strategic Initiatives at Wroclaw Medical University.

Current Role and Leadership 🌍

Prof. Dr. Dominiak currently serves as Vice Rector for Internationalization at Wroclaw Medical University (2024-2028) and as the Director of the European Master Degree in Oral Implantology (MSc). She is also a key leader in several international dental committees, such as the FDI (World Dental Federation), and in the Polish Dental Association. Prof. Dr. Dominiak is committed to advancing dental education, including through her position as Vice Chair of the FDI Section Women Dentist Worldwide and her participation in global continuing education initiatives.

Scientific Achievements and Awards 🏆

Prof. Dr. Dominiak has received numerous prestigious awards for her research in dental surgery and implantology. Notable recognitions include the Rector Ernst-Moritz-Arndt Greifswald University Award in 2010 for Polish-German cooperation, the DGZI Implant Dentistry Award in 2010, and the “Zloty Scalpel” (Gold Scalpel) Award in 2020 for her work in personalized 3D oro-facial reconstruction. Her research in bone regeneration, gingival augmentation, and implantology has earned her several international accolades, establishing her as a leading expert in these areas.

Innovations and Patents 💡

Prof. Dr. Dominiak is an innovator with multiple patents. In 2010, she patented a method for culturing human fibroblasts, a major contribution to tissue engineering. She also holds patents related to assessing the risk of gum and bone loss, as well as a method for creating a transplant to address bone defects in the jaw, reflecting her ongoing influence in dental innovation.

Contributions to Global Dental Education 🌐

Prof. Dr. Dominiak has made significant contributions to global dental education. She has been an active member of several committees focused on dental education, including the FDI Education Committee, and has led the Task Team on Digital Cleft Care. Her efforts to standardize and enhance dental education and care have solidified her role as a prominent figure in both academic research and clinical practice worldwide.

Top Noted Publications 📖

Blended intensive programme’s implementation in dental education: post-pandemic evolution of learning
    • Authors: Duś-Ilnicka, I., Paradowska-Stolarz, A., Mazur, M., Sousa Gomes, P.D., Dominiak, M.
    • Journal: BMC Medical Education
    • Year: 2024
Studies on the content of toxic metals in teeth: A narrative review of literature
    • Authors: Rayad, S., Klimas, S., Janeczek, M., Dominiak, M., Dobrzyński, M.
    • Journal: Dental and Medical Problems
    • Year: 2024
Advancements in alveolar bone reconstruction: A systematic review of bone block utilization in dental practice
    • Authors: Hnitecka, S., Olchowy, C., Olchowy, A., Dąbrowski, P., Dominiak, M.
    • Journal: Dental and Medical Problems
    • Year: 2024
Analysis of aerosol generation during Er:YAG laser-assisted caries treatment: A randomized clinical trial
    • Authors: Matys, J., Gedrange, T., Dominiak, M., Grzech-Leśniak, K.
    • Journal: Advances in Clinical and Experimental Medicine
    • Year: 2024
Gingival Augmentation Using Injectable Platelet-Rich Fibrin (i-PRF)—A Systematic Review of Randomized Controlled Trials
    • Authors: Żurek, J., Niemczyk, W., Dominiak, M., Wiench, R., Skaba, D.
    • Journal: Journal of Clinical Medicine
    • Year: 2024

Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

Dr. Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

The Ohio State University, United States

Author Profiles

Orcid

Google Scholar

Research Gate

Early Academic Pursuits 🎓

Dr. Rituraj Upadhyay began his academic journey with a strong foundation in medical education at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. There, he completed his Bachelor of Medicine and Surgery (MBBS) in 2014, followed by an MD in Radiation Oncology (2017). His early medical training was marked by a deep interest in radiotherapy and oncology, leading him to pursue a Diplomate of National Board (DNB) certification in Radiation Oncology. His academic endeavors during this time reflected a commitment to advancing medical knowledge and improving patient care through radiation oncology.

Professional Endeavors 🌍

Dr. Upadhyay’s professional career has been driven by a passion for advancing radiation oncology, particularly through his work in clinical and academic settings. His residency at The Ohio State University Wexner Medical Center (2021–2025) is a notable highlight in his professional journey, demonstrating his commitment to mastering the latest technologies and treatments in radiation oncology. Dr. Upadhyay’s time at renowned institutions like MD Anderson Cancer Center and Rutgers Cancer Institute of New Jersey has further solidified his standing as an emerging leader in the field. His pursuit of innovation and excellence is evident from his involvement in advanced radiation oncology fellowships and international research collaborations.

Contributions and Research Focus 🔬

Dr. Upadhyay’s research is at the forefront of radiation oncology, with a focus on improving treatment outcomes and minimizing side effects. He has contributed significantly to clinical trials and funded research, such as the “PRIMe-STAR trial” on progressive/recurrent intracranial meningiomas and the “AVATAR” system aimed at reducing anesthesia needs in pediatric radiotherapy. His research on stereotactic radiosurgery for brain metastases and radiation therapy for conditions like penile cancer and renal stereotactic ablative therapy underscores his diverse interests in cancer treatment. His studies have potential global impact, as reflected in his leadership role in multinational research endeavors.

Impact and Influence 🌟

Dr. Upadhyay’s influence extends beyond his research. As an educator and mentor, he actively shapes the next generation of radiation oncologists. His roles in mentoring medical students, residents, and fellows at institutions like The Ohio State University and Massachusetts General Hospital highlight his dedication to guiding aspiring professionals. He also plays a key role in enhancing the field through his involvement in various professional organizations such as the American Society for Radiation Oncology (ASTRO) and the Radiosurgery Society (RSS). His work as a guideline reviewer and committee member for several radiation oncology societies reflects his broad influence on the development of standards and best practices in the field.

Academic Cites 📚

Dr. Upadhyay’s research and academic work are well-regarded, with his contributions earning recognition through numerous awards and honors. Notable accolades include the American College of Radiation Oncology (ACRO) Best Abstract Award and the American Radium Society (ARS) Early Career Oncologist Award, which are testaments to his influential research on topics like stereotactic radiosurgery and palliative radiation therapy. These accolades further cement his reputation in the academic community, demonstrating the high regard in which his peers hold his research.

Technical Skills 💻

Dr. Upadhyay has developed a comprehensive set of technical skills that position him at the cutting edge of radiation oncology. His expertise spans advanced radiation therapy techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, and image-guided brachytherapy. In addition, he is well-versed in cutting-edge technologies, including the use of artificial intelligence and machine learning in radiation oncology for treatment planning and quality assurance. His technical acumen is further demonstrated by his involvement in developing new approaches to enhance clinical outcomes for complex cancer cases.

Teaching Experience 📖

Dr. Upadhyay has dedicated substantial time to teaching and mentorship, sharing his expertise with medical students, residents, and fellow researchers. He has served as a moderator for educational webinars and a mentor for various research initiatives. His roles as a panelist and speaker at international conferences, such as the ASTRO Annual Meeting and the Ohio State University Cardio-Oncology Symposium, reflect his commitment to advancing education within the field of oncology. Through these initiatives, he has played a key role in shaping the future of radiation oncology education.

Legacy and Future Contributions 🔮

Dr. Upadhyay’s legacy in radiation oncology is already being established through his groundbreaking research and mentorship. His involvement in international clinical trials, such as the AVATAR system and the PRIMe-STAR trial, is likely to make a long-lasting impact on the clinical management of cancer patients globally. Looking forward, Dr. Upadhyay plans to continue advancing his research, particularly in the areas of stereotactic radiosurgery and precision medicine. His work promises to significantly shape the future of radiation oncology, particularly in improving treatment efficacy, minimizing side effects, and enhancing patient care across diverse populations.

 

Top Noted Publications 📖

Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas

Authors: Divya Yadav, Rituraj Upadhyay, Vinodh A. Kumar, Melissa M. Chen, Jason M. Johnson, Holly Langshaw, Brandon J. Curl, Maguy Farhat, Wasif Talpur, Thomas H. Beckham et al.

Journal: Practical Radiation Oncology

Year: 2024

Risk-Stratified Radiotherapy in Pediatric Cancer

Authors: Rituraj Upadhyay, Arnold C. Paulino

Journal: Cancers

Year: 2024

Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients

Authors: Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink et al.

Journal: Cancers

Year: 2024

Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury after Proton Beam Radiation in Pediatric Brain Tumors

Authors: Rituraj Upadhyay, Kaiping Liao, David R Grosshans, Susan L McGovern, Mary Frances McAleer, Wafik Zaky, Murali M Chintagumpala, Anita Mahajan, Debra Nana Yeboa, Arnold C Paulino

Journal: Neuro-Oncology

Year: 2022

Patterns of Failure after Radiation Therapy in Primary Spinal High-Grade Gliomas: A Single Institutional Analysis

Authors: Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison et al.

Journal: Neuro-Oncology Advances

Year: 2022

Hao Gao | Healthcare Data Analysis | Best Researcher Award

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024

Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Dr. Tahar Kernif | Healthcare Data Analysis | Excellence in Research

Institut Pasteur Algérie, Algeria

Author Profile

🎓 Early Academic Pursuits

Dr. Tahar Kernif’s academic journey began in 2004 when he completed his Doctorate in Veterinary Science at the École Nationale Vétérinaire d’Alger, where he conducted a comparative study on treatments for canine Leishmaniasis. This research laid the foundation for his future work in veterinary parasitology. Dr. Kernif then pursued a Magistère in Parasitology at the same institution, focusing on zoonotic diseases and vectors, which further honed his expertise in vector-borne infections. These early academic achievements earned him distinction and sparked his lifelong commitment to studying infectious diseases.

🧑‍🔬 Professional Endeavors

Since 2013, Dr. Kernif has been a Maître de Recherche at the Institut Pasteur d’Alger, where he works on molecular techniques to study parasitic diseases in veterinary science. His research focuses on Protozoa, Helminths, and the molecular ecology of arthropod vectors. He has played an integral role in shaping the institute’s research activities on infectious diseases and environmental health, contributing to key initiatives in the field of veterinary parasitology. Dr. Kernif’s professional work is also marked by collaborations with international research institutions such as CIRAD and IRD, where he has worked on studying arthropod microbiota through meta-proteomics.

🔬 Contributions and Research Focus

Dr. Kernif’s primary research interests lie in Infectious Diseases and Health and Environment, specifically focusing on multi-omics approaches to understanding pathogen behavior. His work spans genomics, metagenomics, and proteomics, applying these techniques to study diseases like leishmaniasis and tick-borne infections. His research includes phylogenetic analysis and bioinformatic modeling, which have contributed significantly to the molecular understanding of parasite-host interactions, providing insights into disease transmission and control strategies.

🌍 Impact and Influence

Dr. Kernif’s contributions extend beyond research, as he is actively involved in national health policy and scientific review boards. He served as associate editor for New Microbes and New Infections and has been a scientific examiner for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). His work has shaped policies related to biodiversity and environmental health, especially in Algeria, where he is part of the National Expert Working Group for the Libreville Declaration on Health and Environment. His influence on public health and policy is a testament to his broad impact in both scientific and governmental circles.

📚 Academic Cites

Dr. Kernif has authored 35 international publications and contributed to two book chapters, demonstrating his prominent role in infectious disease research. His studies are frequently cited in scientific journals, reflecting his influence in veterinary parasitology and zoonotic diseases. His work in molecular epidemiology and vector-borne pathogens has made a lasting impact on the field and continues to guide contemporary research.

🛠️ Technical Skills

Dr. Kernif is highly proficient in a range of advanced techniques critical to research in parasitology and microbiology. His expertise spans capillary sequencing, next-generation sequencing (NGS), and PCR/qPCR, which are essential for molecular surveillance and unraveling genetic information. He is also skilled in MALDI-TOF Mass Spectrometry, currently in progress, allowing for detailed molecular analysis of pathogens. Additionally, Dr. Kernif utilizes bioinformatics to analyze complex datasets, helping to interpret vast amounts of biological data. His proficiency in meta-proteomics is instrumental in studying the microbiota of arthropods, providing insights into disease mechanisms and transmission. These tools equip Dr. Kernif with the ability to conduct precise and impactful research, advancing our understanding of infectious diseases.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Kernif has shared his expertise through academic mentorship and scientific training. As a researcher at the Institut Pasteur d’Alger, he supervises graduate students and engages in international collaborations to promote knowledge exchange. His teaching and mentorship in the field of veterinary parasitology and infectious diseases continue to shape the next generation of scientists.

🌱 Legacy and Future Contributions

Dr. Kernif’s legacy is marked by his scientific publications, international collaborations, and his influence in shaping research policy in infectious diseases. Moving forward, his research is poised to address emerging health threats, particularly those arising from vector-borne diseases. His continued contributions to global health initiatives and his work on disease surveillance are expected to leave a lasting mark on the fields of veterinary entomology and infectious disease control.

 

📖 Top Noted Publications

Update on tick-borne rickettsioses around the world: a geographic approach
    • Authors: P Parola, CD Paddock, C Socolovschi, MB Labruna, O Medianikov, …
    • Journal: Clinical Microbiology Reviews
    • Year: 2013
Borrelia, Rickettsia, and Ehrlichia species in bat ticks, France, 2010
    • Authors: C Socolovschi, T Kernif, D Raoult, P Parola
    • Journal: Emerging Infectious Diseases
    • Year: 2012
Matrix-assisted laser desorption ionization–time of flight mass spectrometry for rapid identification of tick vectors
    • Authors: A Yssouf, C Flaudrops, R Drali, T Kernif, C Socolovschi, JM Berenger, …
    • Journal: Journal of Clinical Microbiology
    • Year: 2013
Identification of flea species using MALDI-TOF/MS
    • Authors: A Yssouf, C Socolovschi, H Leulmi, T Kernif, I Bitam, G Audoly, L Almeras, …
    • Journal: Comparative Immunology, Microbiology and Infectious Diseases
    • Year: 2014
Rickettsiae of spotted fever group, Borrelia valaisiana, and Coxiella burnetii in ticks on passerine birds and mammals from the Camargue in the south of France
    • Authors: C Socolovschi, P Reynaud, T Kernif, D Raoult, P Parola
    • Journal: Ticks and Tick-Borne Diseases
    • Year: 2012

Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan | Medical Diagnostics | Best Researcher Award

Dr. Laurence Vaughan at Becton Dickinson and Company, United States

👨‍🎓 Professional Profile

🎓 Early Academic Pursuits

Dr. Laurence Vaughan began his academic journey at the University of Dublin, Trinity College, where he earned a BA (Honors) in Natural Sciences (Genetics) in 1986, followed by a Ph.D. in Molecular Microbiology in 1991. His doctoral research focused on the aroA gene of Aeromonas salmonicida, contributing to foundational knowledge in microbiology and vaccine development.

🏢 Professional Endeavors

Dr. Vaughan’s career spans over three decades in the biotechnology and molecular diagnostics sectors. Currently, he serves as the Director of Scientific Affairs at Becton Dickinson and Company, focusing on integrated diagnostic solutions for women’s health, particularly cervical cancer screening. His past roles include R&D leadership at QIAGEN and Corning Incorporated, where he made significant advancements in molecular assay development and product support.

🌟 Contributions and Research Focus

Dr. Vaughan has led teams in developing groundbreaking products such as the BD Onclarity cervical cancer screening test, which received CE Mark approval in 2014 and US-PMA approval in 2018. He has authored content for international conferences and peer-reviewed publications, emphasizing his commitment to advancing scientific knowledge and product innovation in the diagnostics field.

🌍 Impact and Influence

His work has not only shaped diagnostic guidelines but has also influenced industry standards, as seen with the American Society for Colposcopy and Cervical Pathology (ASCCP) management guidelines launched in 2020. Dr. Vaughan’s expertise is recognized internationally, making him a sought-after speaker at various conferences.

📚 Academic Cites

Dr. Vaughan has made notable contributions to the field of vaccinology, evidenced by multiple patents and publications. His editorial experience as the Editor-in-Chief of “Diseases of Aquatic Organisms” from 1995 to 1999 further underscores his leadership in academic discourse.

🔧 Technical Skills

Dr. Vaughan possesses extensive technical skills in molecular biology, microbiology, and genetics. His proficiency in managing clinical trials, particularly in the R&D lead for Onclarity HPV clinical trials, highlights his ability to oversee complex scientific projects.

👩‍🏫 Teaching Experience

Throughout his career, Dr. Vaughan has demonstrated a passion for education and mentorship. He has developed and delivered training for global customers and internal teams, showcasing his strong communication and interpersonal skills.

🏅 Legacy and Future Contributions

Dr. Vaughan’s legacy includes a robust portfolio of innovations and leadership in the biotech field. His achievements, such as the Becton Dickinson Wesley J. Howe Award for Technological Innovation in 2013, reflect his dedication to advancing science and technology. Looking ahead, he aims to continue contributing to the development of effective diagnostic solutions and vaccines, focusing on emerging health challenges.

 

📖 Top Noted Publications

Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening

Authors: Vaughan, L., Gary, D., Shah, M., Galbraith, L., Parvu, V.
Journal: Gynecologic Oncology Reports
Year: 2024

Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial

Authors: Stoler, M.H., Parvu, V., Yanson, K., Andrews, J., Vaughan, L.
Journal: Gynecologic Oncology
Year: 2023

Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay

Authors: Taylor, S., Rucki, A., Lockamy, E., Vaughan, L., Greene, W.
Journal: Journal of Molecular Diagnostics
Year: 2022

Evaluation of the Onclarity HPV assay on the high-throughput COR system

Authors: Taylor, S.N., Eckert, K., Rucki, A.A., Vaughan, L.M., Greene, W.H.
Journal: Expert Review of Molecular Diagnostics
Year: 2021

Cotesting in cervical cancer screening

Authors: Malinowski, D.P., Broache, M., Vaughan, L., Andrews, J., Gary, D.
Journal: American Journal of Clinical Pathology
Year: 2021

Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus

Authors: Young, S., Vaughan, L., Yanson, K., Cooper, C.K., van der Pol, B.
Journal: Journal of Clinical Microbiology
Year: 2021